Duncan Williams Downgrades Obagi Medical Products (OMPI) to Hold; All Is Not Lost
Tweet Send to a Friend
Duncan Williams downgraded Obagi Medical Products (NASDAQ: OMPI) from Buy to Hold.
Duncan analyst says, "(1) We remain on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Duncan analyst says, "(1) We remain on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
